Evotec SE (EVO) 10-Year Financial Performance & Capital Metrics

EVO • • Industrial / General

HealthcareSpecialty & Generic PharmaContract Manufacturing & APICDMO Services

AboutEvotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.Show more

Revenue $797M +2.0%
EBITDA -$41M -190.0%
Net Income -$196M -133.7%
EPS (Diluted) -0.56 -143.5%
Gross Margin 14.41% -35.7%
EBITDA Margin -5.13% -188.2%
Operating Margin -17.88% -194.2%
Net Margin -24.6% -129.1%
ROE -18.92% -160.1%
ROIC -8.5% -224.3%
Debt/Equity 0.47 -36.0%
Interest Coverage -12.18 -201.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 12.3%
✓Trading at only 1.3x book value

✗Weaknesses

✗Negative free cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y24.44%

5Y12.29%

3Y8.85%

TTM-2.67%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM7.23%

EPS CAGR

10Y-

5Y-

3Y-

TTM9.39%

ROCE

10Y Avg4.71%

5Y Avg-0.82%

3Y Avg-3.32%

Latest-8.49%

Peer Comparison

CDMO Services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
LFCRLifecore Biomedical, Inc.	303.48M	8.10	-6.38	0.47%	-24.01%	-88.29%		97.92
EVOEvotec SE	1.29B	3.62	-6.46	1.99%	-21.02%	-19.87%		0.47

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	127.68M	164.51M	257.63M	375.4M	446.44M	500.92M	618.03M	751.45M	781.43M	796.97M
Revenue Growth %	0.43%	0.29%	0.57%	0.46%	0.19%	0.12%	0.23%	0.22%	0.04%	0.02%
Cost of Goods Sold+	89.69M	105.95M	175.06M	263.39M	313.55M	375.18M	466.49M	577.38M	606.38M	682.09M
COGS % of Revenue	0.7%	0.64%	0.68%	0.7%	0.7%	0.75%	0.75%	0.77%	0.78%	0.86%
Gross Profit+	37.99M	58.55M	82.57M	112.02M	132.89M	125.74M	151.54M	174.06M	175.05M	114.88M
Gross Margin %	0.3%	0.36%	0.32%	0.3%	0.3%	0.25%	0.25%	0.23%	0.22%	0.14%
Gross Profit Growth %	0.29%	0.54%	0.41%	0.36%	0.19%	-0.05%	0.21%	0.15%	0.01%	-0.34%
Operating Expenses+	40.52M	21.81M	43.89M	49.22M	58.38M	77.19M	110.55M	153.22M	222.56M	257.4M
OpEx % of Revenue	0.32%	0.13%	0.17%	0.13%	0.13%	0.15%	0.18%	0.2%	0.28%	0.32%
Selling, General & Admin	25.17M	27.01M	42.38M	57.01M	66.43M	77.2M	105.44M	156.19M	169.61M	188.2M
SG&A % of Revenue	0.2%	0.16%	0.16%	0.15%	0.15%	0.15%	0.17%	0.21%	0.22%	0.24%
Research & Development	18.34M	18.11M	17.61M	35.62M	58.43M	59.61M	65.7M	76.64M	68.53M	50.86M
R&D % of Revenue	0.14%	0.11%	0.07%	0.09%	0.13%	0.12%	0.11%	0.1%	0.09%	0.06%
Other Operating Expenses	263K	4K	-209K	257K	-66.6M	-59.63M	-60.6M	-79.62M	-15.58M	18.34M
Operating Income+	11.64M	31.34M	37.49M	77.46M	62.59M	48.56M	41M	20.85M	-47.51M	-142.52M
Operating Margin %	0.09%	0.19%	0.15%	0.21%	0.14%	0.1%	0.07%	0.03%	-0.06%	-0.18%
Operating Income Growth %	2.82%	1.69%	0.2%	1.07%	-0.19%	-0.22%	-0.16%	-0.49%	-3.28%	-2%
EBITDA+	23.58M	43.23M	58.26M	108.76M	111.4M	104.61M	111.39M	104.05M	45.47M	-40.9M
EBITDA Margin %	0.18%	0.26%	0.23%	0.29%	0.25%	0.21%	0.18%	0.14%	0.06%	-0.05%
EBITDA Growth %	9.94%	0.83%	0.35%	0.87%	0.02%	-0.06%	0.06%	-0.07%	-0.56%	-1.9%
D&A (Non-Cash Add-back)	11.94M	11.89M	20.77M	31.29M	48.81M	56.06M	70.4M	83.2M	92.98M	101.62M
EBIT	14.22M	34.47M	26.83M	74.59M	37.96M	34.3M	246.23M	-140.81M	-68.85M	-182.28M
Net Interest Income+	-1.19M	-660K	-358K	-1.69M	-5.22M	-7.13M	-6.98M	-4.81M	-2.48M	-9.26M
Interest Income	533K	863K	903K	898K	2.23M	1.34M	2.27M	8.34M	9.26M	2.44M
Interest Expense	1.73M	1.52M	1.26M	2.59M	7.46M	8.46M	9.25M	13.15M	11.74M	11.7M
Other Income/Expense	851K	1.61M	-11.16M	-5.46M	-6.03M	-22.72M	195.98M	-174.81M	-33.09M	-51.45M
Pretax Income+	12.49M	32.95M	26.33M	72M	56.56M	25.84M	236.98M	-153.96M	-80.59M	-193.98M
Pretax Margin %	0.1%	0.2%	0.1%	0.19%	0.13%	0.05%	0.38%	-0.2%	-0.1%	-0.24%
Income Tax+	-4.03M	6.11M	2.33M	-12.06M	19.33M	19.56M	21.47M	21.7M	3.32M	2.1M
Effective Tax Rate %	1.32%	0.84%	0.92%	1.17%	0.67%	0.24%	0.91%	1.14%	1.04%	1.01%
Net Income+	16.52M	27.53M	24.26M	84.17M	38.16M	6.28M	215.51M	-175.66M	-83.91M	-196.08M
Net Margin %	0.13%	0.17%	0.09%	0.22%	0.09%	0.01%	0.35%	-0.23%	-0.11%	-0.25%
Net Income Growth %	3.37%	0.67%	-0.12%	2.47%	-0.55%	-0.84%	33.33%	-1.82%	0.52%	-1.34%
Net Income (Continuing)	16.52M	27.21M	25M	84.06M	37.31M	6.28M	215.51M	-175.66M	-83.91M	-196.08M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	1.59M	901K	992K	876K	0	0	0	0	0	0
EPS (Diluted)+	0.06	0.10	0.08	0.28	0.13	0.02	0.65	-0.49	-0.23	-0.56
EPS Growth %	3.26%	0.67%	-0.2%	2.5%	-0.54%	-0.85%	31.5%	-1.75%	0.53%	-1.43%
EPS (Basic)	0.07	0.10	0.08	0.28	0.13	0.02	0.65	-0.49	-0.23	-0.56
Diluted Shares Outstanding	275.27M	265.01M	290.02M	294.96M	299.45M	307.5M	332.81M	353.41M	353.87M	354.59M
Basic Shares Outstanding	263.36M	265.01M	290.02M	294.96M	299.45M	307.5M	332.81M	353.35M	353.87M	353.29M
Dividend Payout Ratio	0.03%	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	166.94M	169.24M	180.25M	249.77M	527.05M	806.13M	1.1B	1.07B	903.16M	681.96M
Cash & Short-Term Investments	134.96M	127.86M	101.58M	149.88M	359.22M	589.67M	858.5M	707.31M	604.11M	396.8M
Cash Only	44.5M	83.94M	67.02M	109.06M	310.97M	517.05M	699.33M	400.7M	510.91M	306.39M
Short-Term Investments	90.46M	43.92M	34.56M	40.82M	48.25M	72.62M	159.17M	306.61M	93.2M	90.41M
Accounts Receivable	22.19M	29.83M	69.98M	60.94M	139.34M	167.48M	176.75M	275.77M	221.9M	218.38M
Days Sales Outstanding	63.44	66.18	99.14	59.25	113.92	122.03	104.39	133.95	103.65	100.02
Inventory	3.13M	4.3M	9.02M	5.66M	12.07M	16.62M	25.79M	29.82M	30.89M	31.12M
Days Inventory Outstanding	12.75	14.83	18.8	7.84	14.05	16.17	20.18	18.85	18.59	16.65
Other Current Assets	3.39M	2.68M	17.03M	25.27M	6.13M	21.04M	20.68M	43.82M	27.87M	13.42M
Total Non-Current Assets+	121.6M	182.13M	487.02M	522.11M	852.81M	1.03B	1.13B	1.18B	1.35B	1.23B
Property, Plant & Equipment	38.33M	43.42M	74.66M	90.52M	268.53M	412.7M	484.6M	650.2M	806.56M	823.94M
Fixed Asset Turnover	3.33x	3.79x	3.45x	4.15x	1.66x	1.21x	1.28x	1.16x	0.97x	0.97x
Goodwill	45.65M	93.23M	220.18M	220.79M	287.27M	302.67M	257.57M	274.82M	275.63M	282.85M
Intangible Assets	25.15M	22.45M	135.03M	122.99M	131.33M	119.95M	30.85M	23.82M	15.45M	26.44M
Long-Term Investments	80K	3.97M	22.14M	28.99M	46.31M	72.22M	287.01M	150.33M	142.09M	42.15M
Other Non-Current Assets	3.57M	8.47M	15.77M	15.5M	26.56M	45.73M	56.84M	74.08M	95.23M	37.82M
Total Assets+	288.54M	351.37M	667.27M	771.88M	1.38B	1.84B	2.24B	2.26B	2.25B	1.91B
Asset Turnover	0.44x	0.47x	0.39x	0.49x	0.32x	0.27x	0.28x	0.33x	0.35x	0.42x
Asset Growth %	0.28%	0.22%	0.9%	0.16%	0.79%	0.33%	0.22%	0.01%	-0%	-0.15%
Total Current Liabilities+	56.4M	73.39M	245.78M	196.28M	200.88M	255.06M	324.52M	337.71M	464.57M	344.58M
Accounts Payable	12.17M	12M	26.08M	31.14M	35.16M	52.06M	72.6M	97.28M	134.32M	85.79M
Days Payables Outstanding	49.53	41.33	54.37	43.15	40.92	50.65	56.8	61.49	80.85	45.91
Short-Term Debt	14.21M	21.41M	167.76M	55.07M	23.27M	36.72M	36.14M	1.56M	149.1M	50.8M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	6.91M	10.23M	29.44M	16.74M	17.17M	31.68M	63.93M	76.54M	45.83M	84.21M
Current Ratio	2.96x	2.31x	0.73x	1.27x	2.62x	3.16x	3.39x	3.18x	1.94x	1.98x
Quick Ratio	2.90x	2.25x	0.70x	1.24x	2.56x	3.10x	3.31x	3.09x	1.88x	1.89x
Cash Conversion Cycle	26.66	39.68	63.57	23.95	87.04	87.56	67.77	91.31	41.39	70.76
Total Non-Current Liabilities+	45.04M	64.04M	89.75M	150.73M	643.51M	696.2M	532.96M	732.36M	667.99M	615.39M
Long-Term Debt	8.73M	7.19M	20.3M	54.68M	364.68M	405.02M	326.34M	328.3M	477.11M	392.74M
Capital Lease Obligations	0	30K	1.17M	2.87M	131.87M	160.21M	135.96M	162M	170.03M	0
Deferred Tax Liabilities	1.54M	115K	23.5M	21.52M	78.08M	73.39M	17.69M	18.52M	18.14M	14.52M
Other Non-Current Liabilities	28.27M	15.57M	16.11M	20.62M	25.3M	25.62M	18.49M	17.4M	-152.57M	20.9M
Total Liabilities	101.44M	137.43M	335.52M	347M	844.39M	951.26M	857.48M	1.07B	1.13B	959.98M
Total Debt+	22.94M	28.83M	189.93M	114.47M	519.83M	601.94M	512.92M	506.67M	815.35M	443.54M
Net Debt	-21.55M	-55.11M	122.91M	5.41M	208.86M	84.9M	-186.41M	105.98M	304.44M	137.15M
Debt / Equity	0.12x	0.13x	0.57x	0.27x	0.97x	0.68x	0.37x	0.43x	0.73x	0.47x
Debt / EBITDA	0.97x	0.67x	3.26x	1.05x	4.67x	5.75x	4.60x	4.87x	17.93x	-
Net Debt / EBITDA	-0.91x	-1.27x	2.11x	0.05x	1.87x	0.81x	-1.67x	1.02x	6.70x	-
Interest Coverage	6.74x	20.58x	29.73x	29.90x	8.40x	5.74x	4.43x	1.59x	-4.05x	-12.18x
Total Equity+	187.09M	213.94M	331.75M	424.88M	535.47M	886.41M	1.38B	1.19B	1.12B	952.52M
Equity Growth %	0.18%	0.14%	0.55%	0.28%	0.26%	0.66%	0.55%	-0.14%	-0.06%	-0.15%
Book Value per Share	0.68	0.81	1.14	1.44	1.79	2.88	4.14	3.36	3.16	2.69
Total Shareholders' Equity	185.5M	213.03M	330.75M	424M	535.47M	886.41M	1.38B	1.19B	1.12B	952.52M
Common Stock	132.58M	133.05M	147.53M	149.06M	169.39M	200.56M	176.61M	176.95M	177.19M	177.55M
Retained Earnings	-622.31M	-592.93M	-566.73M	-481.01M	-495.22M	-529.36M	-216.42M	-392.38M	-476.29M	-672.37M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-18.51M	-25.15M	-28.9M	-27.2M	-21.96M	-45.91M	-12.64M	-37.4M	-30.64M	-7.35M
Minority Interest	1.59M	901K	992K	876K	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	15.65M	67.36M	10.83M	156.24M	42.22M	44.72M	122.24M	205.81M	36.44M	18.22M
Operating CF Margin %	0.12%	0.41%	0.04%	0.42%	0.09%	0.09%	0.2%	0.27%	0.05%	0.02%
Operating CF Growth %	5.12%	3.3%	-0.84%	13.43%	-0.73%	0.06%	1.73%	0.68%	-0.82%	-0.5%
Net Income	16.52M	26.84M	24M	84.06M	37.31M	6.25M	215.51M	-175.66M	-83.91M	-196.08M
Depreciation & Amortization	11.94M	11.89M	20.77M	31.29M	48.8M	56.06M	67.61M	83.2M	92.98M	101.62M
Stock-Based Compensation	3.97M	3.98M	2.92M	4.25M	3.65M	5.29M	7.8M	9.92M	9.63M	5.04M
Deferred Taxes	-6.67M	-1.75M	-6.14M	-26.12M	6.74M	7.49M	5.07M	21.7M	3.32M	2.1M
Other Non-Cash Items	-13.61M	7.16M	4.97M	-9.17M	14.61M	6.51M	-171.47M	161.37M	24.37M	173.75M
Working Capital Changes	3.49M	19.23M	-35.68M	71.93M	-68.9M	-36.87M	-2.28M	105.28M	-9.94M	-68.21M
Change in Receivables	4.42M	-4.11M	-7.88M	-1.85M	-49.33M	-4.18M	-48.03M	-53.68M	0	0
Change in Inventory	-5K	-360K	814K	-283K	-1.36M	-3.63M	-11.65M	-4.41M	0	0
Change in Payables	-8.81M	-1.3M	1.9M	5.01M	-2.03M	2.17M	31.34M	24.55M	0	0
Cash from Investing+	-23.42M	-5.97M	-269.03M	-39.13M	-86.63M	-155.09M	-243.85M	-412.8M	-13.29M	-71.19M
Capital Expenditures	-11.5M	-10.15M	-17.59M	-27.87M	-31.32M	-99.07M	-118.94M	-181.35M	-213.32M	-117.47M
CapEx % of Revenue	0.09%	0.06%	0.07%	0.07%	0.07%	0.2%	0.19%	0.24%	0.27%	0.15%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-49.39M	44.45M	691K	-2.14M	-583K	-6.24M	-7.38M	3.03M	8.22M	-2.78M
Cash from Financing+	2.49M	-19.67M	240.72M	-77.76M	211.26M	246.41M	398.43M	-58.15M	71.96M	-161.42M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-551K	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-551K	53K	2.11M	1.58M	1.9M	1.59M	-20.66M	-5.39M	-12.63M	-9.35M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	4.16M	57.21M	-6.76M	128.37M	10.31M	-54.35M	3.29M	24.46M	-179.56M	-114.02M
FCF Margin %	0.03%	0.35%	-0.03%	0.34%	0.02%	-0.11%	0.01%	0.03%	-0.23%	-0.14%
FCF Growth %	1.46%	12.77%	-1.12%	19.99%	-0.92%	-6.27%	1.06%	6.42%	-8.34%	0.37%
FCF per Share	0.02	0.22	-0.02	0.44	0.03	-0.18	0.01	0.07	-0.51	-0.32
FCF Conversion (FCF/Net Income)	0.95x	2.45x	0.45x	1.86x	1.11x	7.12x	0.57x	-1.17x	-0.43x	-0.09x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	9.56%	13.73%	8.89%	22.25%	7.95%	0.88%	19.04%	-13.7%	-7.27%	-18.92%
Return on Invested Capital (ROIC)	5.88%	14.49%	9.17%	13.13%	7.99%	4.25%	2.84%	1.26%	-2.62%	-8.5%
Gross Margin	29.75%	35.59%	32.05%	29.84%	29.77%	25.1%	24.52%	23.16%	22.4%	14.41%
Net Margin	12.94%	16.73%	9.42%	22.42%	8.55%	1.25%	34.87%	-23.38%	-10.74%	-24.6%
Debt / Equity	0.12x	0.13x	0.57x	0.27x	0.97x	0.68x	0.37x	0.43x	0.73x	0.47x
Interest Coverage	6.74x	20.58x	29.73x	29.90x	8.40x	5.74x	4.43x	1.59x	-4.05x	-12.18x
FCF Conversion	0.95x	2.45x	0.45x	1.86x	1.11x	7.12x	0.57x	-1.17x	-0.43x	-0.09x
Revenue Growth	42.66%	28.85%	56.61%	45.71%	18.92%	12.2%	23.38%	21.59%	3.99%	1.99%

Frequently Asked Questions

Growth & Financials

Evotec SE (EVO) reported $756.3M in revenue for fiscal year 2024. This represents a 844% increase from $80.1M in 2011.

Evotec SE (EVO) grew revenue by 2.0% over the past year. Growth has been modest.

Evotec SE (EVO) reported a net loss of $159.0M for fiscal year 2024.

Dividend & Returns

Evotec SE (EVO) has a return on equity (ROE) of -18.9%. Negative ROE indicates the company is unprofitable.

Evotec SE (EVO) had negative free cash flow of $89.6M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Evotec SE (EVO) 10-Year Financial Performance & Capital Metrics

EVO • • Industrial / General

HealthcareSpecialty & Generic PharmaContract Manufacturing & APICDMO Services

Revenue $797M +2.0%
EBITDA -$41M -190.0%
Net Income -$196M -133.7%
EPS (Diluted) -0.56 -143.5%
Gross Margin 14.41% -35.7%
EBITDA Margin -5.13% -188.2%
Operating Margin -17.88% -194.2%
Net Margin -24.6% -129.1%
ROE -18.92% -160.1%
ROIC -8.5% -224.3%
Debt/Equity 0.47 -36.0%
Interest Coverage -12.18 -201.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 12.3%
✓Trading at only 1.3x book value

✗Weaknesses

✗Negative free cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y24.44%

5Y12.29%

3Y8.85%

TTM-2.67%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM7.23%

EPS CAGR

10Y-

5Y-

3Y-

TTM9.39%

ROCE

10Y Avg4.71%

5Y Avg-0.82%

3Y Avg-3.32%

Latest-8.49%

Peer Comparison

CDMO Services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
LFCRLifecore Biomedical, Inc.	303.48M	8.10	-6.38	0.47%	-24.01%	-88.29%		97.92
EVOEvotec SE	1.29B	3.62	-6.46	1.99%	-21.02%	-19.87%		0.47

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	127.68M	164.51M	257.63M	375.4M	446.44M	500.92M	618.03M	751.45M	781.43M	796.97M
Revenue Growth %	0.43%	0.29%	0.57%	0.46%	0.19%	0.12%	0.23%	0.22%	0.04%	0.02%
Cost of Goods Sold+	89.69M	105.95M	175.06M	263.39M	313.55M	375.18M	466.49M	577.38M	606.38M	682.09M
COGS % of Revenue	0.7%	0.64%	0.68%	0.7%	0.7%	0.75%	0.75%	0.77%	0.78%	0.86%
Gross Profit+	37.99M	58.55M	82.57M	112.02M	132.89M	125.74M	151.54M	174.06M	175.05M	114.88M
Gross Margin %	0.3%	0.36%	0.32%	0.3%	0.3%	0.25%	0.25%	0.23%	0.22%	0.14%
Gross Profit Growth %	0.29%	0.54%	0.41%	0.36%	0.19%	-0.05%	0.21%	0.15%	0.01%	-0.34%
Operating Expenses+	40.52M	21.81M	43.89M	49.22M	58.38M	77.19M	110.55M	153.22M	222.56M	257.4M
OpEx % of Revenue	0.32%	0.13%	0.17%	0.13%	0.13%	0.15%	0.18%	0.2%	0.28%	0.32%
Selling, General & Admin	25.17M	27.01M	42.38M	57.01M	66.43M	77.2M	105.44M	156.19M	169.61M	188.2M
SG&A % of Revenue	0.2%	0.16%	0.16%	0.15%	0.15%	0.15%	0.17%	0.21%	0.22%	0.24%
Research & Development	18.34M	18.11M	17.61M	35.62M	58.43M	59.61M	65.7M	76.64M	68.53M	50.86M
R&D % of Revenue	0.14%	0.11%	0.07%	0.09%	0.13%	0.12%	0.11%	0.1%	0.09%	0.06%
Other Operating Expenses	263K	4K	-209K	257K	-66.6M	-59.63M	-60.6M	-79.62M	-15.58M	18.34M
Operating Income+	11.64M	31.34M	37.49M	77.46M	62.59M	48.56M	41M	20.85M	-47.51M	-142.52M
Operating Margin %	0.09%	0.19%	0.15%	0.21%	0.14%	0.1%	0.07%	0.03%	-0.06%	-0.18%
Operating Income Growth %	2.82%	1.69%	0.2%	1.07%	-0.19%	-0.22%	-0.16%	-0.49%	-3.28%	-2%
EBITDA+	23.58M	43.23M	58.26M	108.76M	111.4M	104.61M	111.39M	104.05M	45.47M	-40.9M
EBITDA Margin %	0.18%	0.26%	0.23%	0.29%	0.25%	0.21%	0.18%	0.14%	0.06%	-0.05%
EBITDA Growth %	9.94%	0.83%	0.35%	0.87%	0.02%	-0.06%	0.06%	-0.07%	-0.56%	-1.9%
D&A (Non-Cash Add-back)	11.94M	11.89M	20.77M	31.29M	48.81M	56.06M	70.4M	83.2M	92.98M	101.62M
EBIT	14.22M	34.47M	26.83M	74.59M	37.96M	34.3M	246.23M	-140.81M	-68.85M	-182.28M
Net Interest Income+	-1.19M	-660K	-358K	-1.69M	-5.22M	-7.13M	-6.98M	-4.81M	-2.48M	-9.26M
Interest Income	533K	863K	903K	898K	2.23M	1.34M	2.27M	8.34M	9.26M	2.44M
Interest Expense	1.73M	1.52M	1.26M	2.59M	7.46M	8.46M	9.25M	13.15M	11.74M	11.7M
Other Income/Expense	851K	1.61M	-11.16M	-5.46M	-6.03M	-22.72M	195.98M	-174.81M	-33.09M	-51.45M
Pretax Income+	12.49M	32.95M	26.33M	72M	56.56M	25.84M	236.98M	-153.96M	-80.59M	-193.98M
Pretax Margin %	0.1%	0.2%	0.1%	0.19%	0.13%	0.05%	0.38%	-0.2%	-0.1%	-0.24%
Income Tax+	-4.03M	6.11M	2.33M	-12.06M	19.33M	19.56M	21.47M	21.7M	3.32M	2.1M
Effective Tax Rate %	1.32%	0.84%	0.92%	1.17%	0.67%	0.24%	0.91%	1.14%	1.04%	1.01%
Net Income+	16.52M	27.53M	24.26M	84.17M	38.16M	6.28M	215.51M	-175.66M	-83.91M	-196.08M
Net Margin %	0.13%	0.17%	0.09%	0.22%	0.09%	0.01%	0.35%	-0.23%	-0.11%	-0.25%
Net Income Growth %	3.37%	0.67%	-0.12%	2.47%	-0.55%	-0.84%	33.33%	-1.82%	0.52%	-1.34%
Net Income (Continuing)	16.52M	27.21M	25M	84.06M	37.31M	6.28M	215.51M	-175.66M	-83.91M	-196.08M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	1.59M	901K	992K	876K	0	0	0	0	0	0
EPS (Diluted)+	0.06	0.10	0.08	0.28	0.13	0.02	0.65	-0.49	-0.23	-0.56
EPS Growth %	3.26%	0.67%	-0.2%	2.5%	-0.54%	-0.85%	31.5%	-1.75%	0.53%	-1.43%
EPS (Basic)	0.07	0.10	0.08	0.28	0.13	0.02	0.65	-0.49	-0.23	-0.56
Diluted Shares Outstanding	275.27M	265.01M	290.02M	294.96M	299.45M	307.5M	332.81M	353.41M	353.87M	354.59M
Basic Shares Outstanding	263.36M	265.01M	290.02M	294.96M	299.45M	307.5M	332.81M	353.35M	353.87M	353.29M
Dividend Payout Ratio	0.03%	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	166.94M	169.24M	180.25M	249.77M	527.05M	806.13M	1.1B	1.07B	903.16M	681.96M
Cash & Short-Term Investments	134.96M	127.86M	101.58M	149.88M	359.22M	589.67M	858.5M	707.31M	604.11M	396.8M
Cash Only	44.5M	83.94M	67.02M	109.06M	310.97M	517.05M	699.33M	400.7M	510.91M	306.39M
Short-Term Investments	90.46M	43.92M	34.56M	40.82M	48.25M	72.62M	159.17M	306.61M	93.2M	90.41M
Accounts Receivable	22.19M	29.83M	69.98M	60.94M	139.34M	167.48M	176.75M	275.77M	221.9M	218.38M
Days Sales Outstanding	63.44	66.18	99.14	59.25	113.92	122.03	104.39	133.95	103.65	100.02
Inventory	3.13M	4.3M	9.02M	5.66M	12.07M	16.62M	25.79M	29.82M	30.89M	31.12M
Days Inventory Outstanding	12.75	14.83	18.8	7.84	14.05	16.17	20.18	18.85	18.59	16.65
Other Current Assets	3.39M	2.68M	17.03M	25.27M	6.13M	21.04M	20.68M	43.82M	27.87M	13.42M
Total Non-Current Assets+	121.6M	182.13M	487.02M	522.11M	852.81M	1.03B	1.13B	1.18B	1.35B	1.23B
Property, Plant & Equipment	38.33M	43.42M	74.66M	90.52M	268.53M	412.7M	484.6M	650.2M	806.56M	823.94M
Fixed Asset Turnover	3.33x	3.79x	3.45x	4.15x	1.66x	1.21x	1.28x	1.16x	0.97x	0.97x
Goodwill	45.65M	93.23M	220.18M	220.79M	287.27M	302.67M	257.57M	274.82M	275.63M	282.85M
Intangible Assets	25.15M	22.45M	135.03M	122.99M	131.33M	119.95M	30.85M	23.82M	15.45M	26.44M
Long-Term Investments	80K	3.97M	22.14M	28.99M	46.31M	72.22M	287.01M	150.33M	142.09M	42.15M
Other Non-Current Assets	3.57M	8.47M	15.77M	15.5M	26.56M	45.73M	56.84M	74.08M	95.23M	37.82M
Total Assets+	288.54M	351.37M	667.27M	771.88M	1.38B	1.84B	2.24B	2.26B	2.25B	1.91B
Asset Turnover	0.44x	0.47x	0.39x	0.49x	0.32x	0.27x	0.28x	0.33x	0.35x	0.42x
Asset Growth %	0.28%	0.22%	0.9%	0.16%	0.79%	0.33%	0.22%	0.01%	-0%	-0.15%
Total Current Liabilities+	56.4M	73.39M	245.78M	196.28M	200.88M	255.06M	324.52M	337.71M	464.57M	344.58M
Accounts Payable	12.17M	12M	26.08M	31.14M	35.16M	52.06M	72.6M	97.28M	134.32M	85.79M
Days Payables Outstanding	49.53	41.33	54.37	43.15	40.92	50.65	56.8	61.49	80.85	45.91
Short-Term Debt	14.21M	21.41M	167.76M	55.07M	23.27M	36.72M	36.14M	1.56M	149.1M	50.8M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	6.91M	10.23M	29.44M	16.74M	17.17M	31.68M	63.93M	76.54M	45.83M	84.21M
Current Ratio	2.96x	2.31x	0.73x	1.27x	2.62x	3.16x	3.39x	3.18x	1.94x	1.98x
Quick Ratio	2.90x	2.25x	0.70x	1.24x	2.56x	3.10x	3.31x	3.09x	1.88x	1.89x
Cash Conversion Cycle	26.66	39.68	63.57	23.95	87.04	87.56	67.77	91.31	41.39	70.76
Total Non-Current Liabilities+	45.04M	64.04M	89.75M	150.73M	643.51M	696.2M	532.96M	732.36M	667.99M	615.39M
Long-Term Debt	8.73M	7.19M	20.3M	54.68M	364.68M	405.02M	326.34M	328.3M	477.11M	392.74M
Capital Lease Obligations	0	30K	1.17M	2.87M	131.87M	160.21M	135.96M	162M	170.03M	0
Deferred Tax Liabilities	1.54M	115K	23.5M	21.52M	78.08M	73.39M	17.69M	18.52M	18.14M	14.52M
Other Non-Current Liabilities	28.27M	15.57M	16.11M	20.62M	25.3M	25.62M	18.49M	17.4M	-152.57M	20.9M
Total Liabilities	101.44M	137.43M	335.52M	347M	844.39M	951.26M	857.48M	1.07B	1.13B	959.98M
Total Debt+	22.94M	28.83M	189.93M	114.47M	519.83M	601.94M	512.92M	506.67M	815.35M	443.54M
Net Debt	-21.55M	-55.11M	122.91M	5.41M	208.86M	84.9M	-186.41M	105.98M	304.44M	137.15M
Debt / Equity	0.12x	0.13x	0.57x	0.27x	0.97x	0.68x	0.37x	0.43x	0.73x	0.47x
Debt / EBITDA	0.97x	0.67x	3.26x	1.05x	4.67x	5.75x	4.60x	4.87x	17.93x	-
Net Debt / EBITDA	-0.91x	-1.27x	2.11x	0.05x	1.87x	0.81x	-1.67x	1.02x	6.70x	-
Interest Coverage	6.74x	20.58x	29.73x	29.90x	8.40x	5.74x	4.43x	1.59x	-4.05x	-12.18x
Total Equity+	187.09M	213.94M	331.75M	424.88M	535.47M	886.41M	1.38B	1.19B	1.12B	952.52M
Equity Growth %	0.18%	0.14%	0.55%	0.28%	0.26%	0.66%	0.55%	-0.14%	-0.06%	-0.15%
Book Value per Share	0.68	0.81	1.14	1.44	1.79	2.88	4.14	3.36	3.16	2.69
Total Shareholders' Equity	185.5M	213.03M	330.75M	424M	535.47M	886.41M	1.38B	1.19B	1.12B	952.52M
Common Stock	132.58M	133.05M	147.53M	149.06M	169.39M	200.56M	176.61M	176.95M	177.19M	177.55M
Retained Earnings	-622.31M	-592.93M	-566.73M	-481.01M	-495.22M	-529.36M	-216.42M	-392.38M	-476.29M	-672.37M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-18.51M	-25.15M	-28.9M	-27.2M	-21.96M	-45.91M	-12.64M	-37.4M	-30.64M	-7.35M
Minority Interest	1.59M	901K	992K	876K	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	15.65M	67.36M	10.83M	156.24M	42.22M	44.72M	122.24M	205.81M	36.44M	18.22M
Operating CF Margin %	0.12%	0.41%	0.04%	0.42%	0.09%	0.09%	0.2%	0.27%	0.05%	0.02%
Operating CF Growth %	5.12%	3.3%	-0.84%	13.43%	-0.73%	0.06%	1.73%	0.68%	-0.82%	-0.5%
Net Income	16.52M	26.84M	24M	84.06M	37.31M	6.25M	215.51M	-175.66M	-83.91M	-196.08M
Depreciation & Amortization	11.94M	11.89M	20.77M	31.29M	48.8M	56.06M	67.61M	83.2M	92.98M	101.62M
Stock-Based Compensation	3.97M	3.98M	2.92M	4.25M	3.65M	5.29M	7.8M	9.92M	9.63M	5.04M
Deferred Taxes	-6.67M	-1.75M	-6.14M	-26.12M	6.74M	7.49M	5.07M	21.7M	3.32M	2.1M
Other Non-Cash Items	-13.61M	7.16M	4.97M	-9.17M	14.61M	6.51M	-171.47M	161.37M	24.37M	173.75M
Working Capital Changes	3.49M	19.23M	-35.68M	71.93M	-68.9M	-36.87M	-2.28M	105.28M	-9.94M	-68.21M
Change in Receivables	4.42M	-4.11M	-7.88M	-1.85M	-49.33M	-4.18M	-48.03M	-53.68M	0	0
Change in Inventory	-5K	-360K	814K	-283K	-1.36M	-3.63M	-11.65M	-4.41M	0	0
Change in Payables	-8.81M	-1.3M	1.9M	5.01M	-2.03M	2.17M	31.34M	24.55M	0	0
Cash from Investing+	-23.42M	-5.97M	-269.03M	-39.13M	-86.63M	-155.09M	-243.85M	-412.8M	-13.29M	-71.19M
Capital Expenditures	-11.5M	-10.15M	-17.59M	-27.87M	-31.32M	-99.07M	-118.94M	-181.35M	-213.32M	-117.47M
CapEx % of Revenue	0.09%	0.06%	0.07%	0.07%	0.07%	0.2%	0.19%	0.24%	0.27%	0.15%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-49.39M	44.45M	691K	-2.14M	-583K	-6.24M	-7.38M	3.03M	8.22M	-2.78M
Cash from Financing+	2.49M	-19.67M	240.72M	-77.76M	211.26M	246.41M	398.43M	-58.15M	71.96M	-161.42M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-551K	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-551K	53K	2.11M	1.58M	1.9M	1.59M	-20.66M	-5.39M	-12.63M	-9.35M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	4.16M	57.21M	-6.76M	128.37M	10.31M	-54.35M	3.29M	24.46M	-179.56M	-114.02M
FCF Margin %	0.03%	0.35%	-0.03%	0.34%	0.02%	-0.11%	0.01%	0.03%	-0.23%	-0.14%
FCF Growth %	1.46%	12.77%	-1.12%	19.99%	-0.92%	-6.27%	1.06%	6.42%	-8.34%	0.37%
FCF per Share	0.02	0.22	-0.02	0.44	0.03	-0.18	0.01	0.07	-0.51	-0.32
FCF Conversion (FCF/Net Income)	0.95x	2.45x	0.45x	1.86x	1.11x	7.12x	0.57x	-1.17x	-0.43x	-0.09x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	9.56%	13.73%	8.89%	22.25%	7.95%	0.88%	19.04%	-13.7%	-7.27%	-18.92%
Return on Invested Capital (ROIC)	5.88%	14.49%	9.17%	13.13%	7.99%	4.25%	2.84%	1.26%	-2.62%	-8.5%
Gross Margin	29.75%	35.59%	32.05%	29.84%	29.77%	25.1%	24.52%	23.16%	22.4%	14.41%
Net Margin	12.94%	16.73%	9.42%	22.42%	8.55%	1.25%	34.87%	-23.38%	-10.74%	-24.6%
Debt / Equity	0.12x	0.13x	0.57x	0.27x	0.97x	0.68x	0.37x	0.43x	0.73x	0.47x
Interest Coverage	6.74x	20.58x	29.73x	29.90x	8.40x	5.74x	4.43x	1.59x	-4.05x	-12.18x
FCF Conversion	0.95x	2.45x	0.45x	1.86x	1.11x	7.12x	0.57x	-1.17x	-0.43x	-0.09x
Revenue Growth	42.66%	28.85%	56.61%	45.71%	18.92%	12.2%	23.38%	21.59%	3.99%	1.99%

Frequently Asked Questions

Growth & Financials

Evotec SE (EVO) reported $756.3M in revenue for fiscal year 2024. This represents a 844% increase from $80.1M in 2011.

Evotec SE (EVO) grew revenue by 2.0% over the past year. Growth has been modest.

Evotec SE (EVO) reported a net loss of $159.0M for fiscal year 2024.

Dividend & Returns

Evotec SE (EVO) has a return on equity (ROE) of -18.9%. Negative ROE indicates the company is unprofitable.

Evotec SE (EVO) had negative free cash flow of $89.6M in fiscal year 2024, likely due to heavy capital investments.